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Key Features
 The Africa Centre Demographic Information System (ACDIS) cohort in rural 
KwaZulu Natal, South Africa, was established in 2000. In 2017, the cohort 
expanded and renamed the Population Intervention Platform (PIP).
 Public health priorities in South Africa have changed over the past 20 years, with 
widespread availability of ART and a growing burden of non-communicable 
disease (NCD).  AHRI’s research programme has shifted to address these new 
priorities, and to deliver and evaluate interventions.
 In mid-2018, the cohort had approximately 140,000 individuals (median age=23 
years, IQR=11-36), of whom 66% were members of households in the original 
ACDIS cohort.
 New questions include additional household socioeconomic indicators, and 
diagnosis and treatment of HIV, TB and NCDs.  Attendance at clinics in the PIP 
area is captured.  New linkages to routine data provide information on 
treatment, morbidity, health service usage, and a range of health outcomes.
 Data can be accessed through the AHRI data repository 
(https://data.ahri.org/index.php/home). 
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The original cohort 
The Africa Centre Demographic Information System (ACDIS) was established in 2000 by 
the Africa Health Research Institute (AHRI; formerly the Africa Centre for Health and 
Population Studies), funded by the Wellcome Trust.  The aim of ACDIS was to describe 
the demographic, social and health impacts of a rapidly progressing HIV epidemic in 
rural South Africa, and to monitor the impact of intervention strategies.  An initial 
cohort profile was published in 2008 and described findings from the first six years of 
data collection.[1]
The original ACDIS surveillance area covered 438 km2 in uMkhanyakude district, 
KwaZulu-Natal province, South Africa, and included a population of approximately 
85,000 resident and non-resident individuals in 11,000 households in 2006.  
Households are contacted three times annually to record information on births, deaths 
and migration patterns of all household members, including non-residents.  Resident 
members aged ≥15 years are invited to participate in an annual individual-level survey, 
which includes an interview on general health and sexual behaviour, and collection of a 
dried blood spot (DBS) for anonymised HIV testing.  Geographic coordinates are 
available for each homestead, allowing spatial analysis.  In 2017, the ACDIS area was 
expanded to 845km2 and renamed the Population Intervention Programme (PIP), with 
around 140,000 individuals (20,00 households) in 2018, including the communities of a 
recent cluster-randomised trial (CRT) of HIV treatment (Figure 1).[2]
What is the reason for the new focus?  
ACDIS has made important contributions to our understanding of the HIV epidemic.  
However, despite significant increases in antiretroviral therapy (ART) coverage, HIV 
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incidence remains high.  South Africa has the largest number of people living with HIV 
worldwide, estimated at 7.7 million in 2018.  In the PIP area, HIV incidence among 
women aged 15‒24 years in 2011‒2015 was estimated at 6.2/100 person-years.[3]   
Incidence has declined more recently, with marked reductions between 2014‒2017 
among young women.[4]
Moreover, the HIV prevention landscape has changed considerably since the initiation 
of the original ACDIS cohort.  The scale up of ART (first rolled out in the surveillance 
area in 2004) has had a major impact on the health and life expectancy of HIV positive 
individuals.[5]  However, new infections need to be prevented to bring an end to the 
HIV pandemic.  Effective HIV prevention will require a combination of biomedical, 
behavioural and structural interventions that will need to be tested at the population 
level.
Aside from HIV, there is a rapidly changing burden of disease in the region. Tuberculosis 
(TB( is responsible for >30% of deaths in KwaZulu Natal, and uMkhanyakude district 
has a high prevalence of rifampicin resistance (9.9% of TB cases vs. 6.9% nationally in 
2017).[6]  In parallel, South Africa is experiencing a growing burden of non-
communicable diseases (NCD), especially diabetes, cardiovascular disease, 
hypertension, kidney disease and cancer.  Injuries (both traffic accidents and violence) 
are also an important cause of death.[7]  As the public health priorities in rural South 
Africa have shifted significantly over the past 20 years, our research programme has 
made a parallel shift to address these new priorities.  In addition, our focus has changed 
from descriptive epidemiology to delivering and evaluating interventions. 
Lastly, advances in surveillance methods have resulted in changes to our survey 
methodology.  The collection of clinical data requires an efficient and reliable way of 
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communicating results to individuals, and of linking those who require care to 
appropriate services.  Advances in technology have also allowed us to introduce 
telephonic and electronic data capture.
What will be the new areas of research?  
AHRI continues to focus its research on HIV, and has extended to TB, NCDs, and the 
interaction of chronic infections with NCDs.  New areas of research will include the 
pathogenesis and prevention of HIV and TB, and the biological, structural and social 
reasons for continued HIV transmission despite widespread ART use.  In October 2016, 
South Africa implemented the new WHO universal test and treat (UTT) guidelines, 
whereby ART is offered to all individuals living with HIV. With increasing numbers of 
individuals on ART, PIP allows exploration of host and viral determinants of responses 
to therapy and HIV disease progression, development of drug resistance mutations, the 
impact of drug resistance on ‘treatment as prevention’ goals, and interactions and 
comorbidities of HIV, TB and NCDs.
New research will also focus on the biological factors associated with susceptibility to 
HIV, including host microbiome and host and viral genetics, to inform new prevention 
approaches.  Stored blood samples from the period before and after HIV acquisition in 
over 3500 individuals provides an opportunity for genetic sequencing to explore 
biological markers of HIV susceptibility. 
A new focus will be on the transmission dynamics of TB, including the origin of drug-
resistant strains and identification of biomarkers that predict treatment success.  PIP 
will also provide a platform for ancillary studies nested within the surveillance cohort.  
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There will be an increased focus on interventions to reduce HIV and TB transmission, as 
well as interventions to improve access to essential health services.  
Who is in the cohort?  
PIP is an open cohort consisting of all households within the expanded surveillance 
area.  As with ACDIS, information is collected on both resident and non-resident 
members who join or leave the cohort at any given time (a resident is defined as an 
individual who intends to sleep the majority of nights in the homestead occupied by the 
household).  In addition to the existing ACDIS cohort, PIP includes the communities of 
the ANRS 12249 Treatment as Prevention trial;[2] households were followed in the trial 
from 2012–2016 and were added to the PIP cohort in 2017.   
Since 2000, 231,179 unique individuals have participated in the cohort, generating over 
2 million person-years of follow-up.  Only 5.2% of individuals have been lost to follow-
up, although members may exit if they leave a member household.  In mid-2018, there 
were 142,079 individuals in the PIP cohort, of whom 93,074 were members of 
households in the original ACDIS surveillance area (Figure 2; Supplementary Table S1).  
Overall, 54% (76,134) of the cohort were female and 28% were non-resident members.
Compared with the 2006 cohort,[1] the population is older: median (IQR) male and 
female ages were 22 years (11-34) and 25 years (12-39) respectively in mid-2018, 
versus 19 years (10-31) and 21 years (11-35) in mid-2006.  Non-resident members 
make up a slightly lower proportion of the population (28% in 2018 vs 34% in 2006).  
Household size is smaller (mean=7.0, SD=4.4 in 2018 vs mean=7.9, SD=4.7 in 2006), and 
many socioeconomic indicators have improved.  Access to electricity and toilet facilities 
have increased to >95% of households; however, access to piped water has declined 
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from 78% in 2006 to 66% in 2018.  Unemployment remains high, with 62% of adults 
without formal employment (similar to 2006); however, receipt of government grants 
has expanded to 39% of household members.  HIV prevalence has increased 
substantially, largely owing to access to ART and improved survival.  Prevalence among 
resident men and women aged 15-54 who provided an anonymous DBS in 2018 was 
19% and 40%, respectively, vs 13% and 25% in 2006 (Supplementary Figure 1).  
Participation in the household-level survey is extremely high (>98%), and has remained 
stable over time.  Participation in the individual-level component in any given year is 
<50% (Supplementary Table S2). However, between 2003–2012, 68% of eligible 
individuals participated in the HIV surveillance at least once and 48% at least twice, 
after five survey rounds.[8]  Participation has increased more recently; between 2013–
2018, these figures were 76% and 53%, respectively.
What has been measured?  
PIP continues to collect much of the information described in the original cohort profile.  
The main changes involve:
1) Reduction in the number of home-based survey visits.  Since 2017, visits to PIP 
households have been reduced to once annually, with telephone interviews twice 
annually to update demographic information.  
2) Capturing questionnaire data electronically and addition of new questions.  
Questionnaires are administered on tablet computers using the Research Electronic 
Data Capture (REDCap) system.[9] Sexual behaviour and other sensitive questions are 
collected by computer-assisted self-interview. Questions have been added to the 
household survey on receipt of government grants, food security, and experience of 
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violence (Table 1).  The verbal autopsy (VA) questionnaire (administered routinely for 
all deaths) has been updated to conform to WHO/InterVA standards.  In the individual 
survey, questions have been added about diagnoses and treatment of HIV, TB, 
hypertension and diabetes. Most recently, COVID-19 surveillance has been 
introduced.[10]
3) Offering home-based HIV counselling and testing (HCT) during the survey visit. 
At the annual home visit, all resident household members aged ≥15 years who are not 
on ART are offered HCT, even if they do not participate in the survey.  Individuals who 
test positive are referred to HIV care at a clinic in the surveillance area.  They are also 
asked to consent to facilitated linkage through AHRI’s new ClinicLink system.
4) Capturing of clinic attendance in the PIP area. AHRI implemented the ClinicLink 
system in 2017, to collect the date and reason of attendance for all individuals who 
attend one of the 11 clinics in the PIP area.  Consenting individuals who are referred to 
care after HCT, or other screening tests, and do not attend a clinic within 10 days are 
sent a reminder text message; those who have still not attended within 30 days are 
contacted by telephone by a trained counsellor, and encouraged to attend for care. 
5) Linkage to routine data sources. An important feature of PIP is the ability to link 
the surveillance data with a range of routine data sources (Table 2; Supplementary 
Figure 2).  The linkage algorithm is initially deterministic, with successive steps based 
on five key linkage variables (South African national identification number, first name, 
surname, sex and date of birth), followed by probabilistic matching on the same five 
variables with manual verification.  Current linked data sources include the national HIV 
care database (TIER.net) with records for all individuals on ART at 17 clinics in the sub-
district.  In 2018, there were 64,785 individuals with a record in TIER.net, of whom 
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17,531 (27%) were members of PIP households.  Among 18,662 individuals in the PIP 
cohort who ever tested positive in the HIV surveillance, 8411 (45%) had a record in 
TIER.net.   Other linked data sources include the Hospital Information System, 
containing data on all admissions to Hlabisa hospital (the local district hospital) since 
2010.  Permission from the relevant government authorities has been granted for 
access to data from the National Health Laboratory Service (NHLS), electronic TB 
registers (now part of TIER.net), and records from the Departments of Health, Social 
Welfare, Home Affairs and Education.  Linkage to these data sources is anticipated in the 
future.  
In 2018/19, AHRI established the Vukuzazi Clinical Phenotype Cohort nested within 
PIP, which included multi-disease screening and collection of a range of bio-measures.  
The linkage of multiple data sources with information collected in the annual PIP 
surveillance or ancillary studies enables a ‘health across the lifespan’ approach to 
research (Figure 3).
Ethical approval for the PIP surveillance, ClinicLink, a d linkage of routine data sources 
was granted by the Biomedical Research Ethics Committee, University of KwaZulu-
Natal, South Africa (BE290/16).  Separate written informed consent is obtained for the 
household survey, the individual surveys, and HCT.  Informed consent is also obtained 
for facilitated linkage to care.  An R50 (~US$3) unconditional food gift voucher is given 
to PIP households during the annual home visit; no other gifts or incentives are given 
for participation.  Clinic attendees provide informed consent to record their visit in 
ClinicLink.  A waiver of individual consent for data linkage to the routine data sources 
has been obtained.  The linked datasets are anonymised such that individuals’ 
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confidentiality will not be compromised through the linkage.  Participants provide 
informed consent to share their anonymised data with researchers.
What has it found? Key findings and publications
Over 800 papers, covering a range of health outcomes, have been published since 2008 
using data collected from the PIP cohort.   Much of this work has been on the 
epidemiology of HIV, including prevention and treatment.  Analyses of PIP data have 
shown the tremendous effect of ART on life expectancy: adult life expectancy in 2003 
(the year before ART became available in the public-sector clinics) was 49.2 years; by 
2011, it had increased to 60.5 years.[5]  PIP data have also provided estimates of the 
effects of community- and household-level ART coverage, and of population HIV viral 
load, on the risk of HIV acquisition.[11-13]  Increased community-level ART coverage 
was also shown to be associated with a decreased risk of TB disease.[14]
Papers have been published on temporal trends in detectable HIV viremia,[15] the HIV 
care cascade,[16] and the effect of ART scale-up.[17]  Studies have examined 
behavioural risk factors for HIV incidence, including the effect of age-disparate 
relationships,[18,19] male circumcision,[20] migration patterns,[21-23] and changes in 
sexual behaviour.[24]
AHRI’s increased focus on interventions included a CRT to increase HIV testing and 
treatment uptake among men,[25] a CRT to evaluate peer-delivery of HIV self-
testing,[26] a stepped-wedge CRT to improve antenatal care,[27] and evaluation of a 
large combination HIV prevention programme among young women.[28,29]  
Recent studies have also examined health service access, linkage to care and clinical 
outcomes.[30,31]  A study of the impact of COVID-19 lockdown showed no decrease in 
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visits to primary health care clinics.[32]  PIP is also a member of the Analysing 
Longitudinal Population-based HIV data on Africa (ALPHA) network and has 
contributed to many multi-site analyses across sub-Saharan Africa.[33]    
What are the main strengths and weaknesses?
A major strength of the PIP cohort is its location and size: it is situated at the centre of 
dual HIV and TB epidemics and is one of the world’s largest population-based HIV 
surveillance studies (with over 3500 prospectively documented HIV seroconversions), 
with wide-ranging longitudinal information measured over 20 years.  The household 
survey has had a consistently high response rate, providing nearly complete data on 
births, deaths and migration patterns.  Data collection is carefully monitored to 
maintain quality, and detailed documentation is available for all datasets.   
Another key strength is the ability to link the cohort data to a wealth of routine data 
sources, providing objective information on HIV treatment, morbidity, health service 
usage, and a range of health outcomes.  As such, the PIP cohort provides a powerful 
resource for HIV, TB and NCD research, and a strong platform to accurately measure 
population dynamics, disease burden, and use of health and other services, and to 
implement and evaluate individual- and population-level interventions.  
An important limitation is the comparatively low response rate on the individual 
components of the annual survey.  However, the existence of a comprehensive sampling 
frame, based on the household survey, makes it possible to examine the extent to which 
representativeness is maintained in the individual components, and to quantify the 
effect of potential biases from non-participation.[34]   Furthermore, most survey data 
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are self-reported and record linkage with routine data is imperfect, so some data may 
fail to be (or be incorrectly) linked.
Can I get hold of the data? Where can I find out more?
PIP data can be accessed through the AHRI data repository 
(https://data.ahri.org/index.php/home),  after self-registration and completion of a 
short data-use agreement form (available online).  Data documentation, including 
questionnaires, technical documents and data dictionaries, is available on the 
repository.
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Table 1. Data collected at household and individual surveys 




Household members (dates of 
birth, sex, relationship to 
household head, marital status, 
residency status), Births, Deaths, 
In- and Out-migration
Three times annually 
since 2000




Household assets, Household 




2001, 2003, 2005, annual 
thereafter, except 2008
2017




Education, Employment Annual since 2003 All individuals who are members of households 
in the surveillance area 
Government 
grants
Receipt of government grants for 
old age, disability, child support, 
etc.
2003, 2005, 2006, annual 
thereafter
All individuals who are members of households 
in the surveillance area 
Individual
HIV status HIV status (from anonymised 
testing)
Annual since 2003 2003-2006:  women 15–49 years and men 15–
54 years resident in surveillance area

































































When last tested 
negative/positive





After 2006, all residents aged ≥15 years 
Sexual behaviour Pregnancy history (women)




Attitudes to condom use
Annual since 2003 2003-2008:  women 15–49 years and men 15–
54 years resident in surveillance area
After 2008, all residents aged ≥15 years 
General health Self-reported:









2003, 2010 all individuals aged ≥15 years resident in 
surveillance area






























































Table 2. Description of data available in linked data sources 
Data source Types of information Description
TIER.net Clinic visits for ART care; viral load; CD4 
counts, ART regimen at initiation; 
changes in ART regimen
Electronic patient records for individuals on ART in 
any of 17 clinics in the Hlabisa health sub-district and 




Admission date; discharge date; ward 
admitted to; ICD10 diagnosis; discharge 
status
All admissions to Hlabisa hospital since 2010, except 
for routine deliveries
ClinicLink Date of visit; reason for visit Individuals attending one of 11 clinics serving the PIP 
surveillance area since 2017
Vukuzazi clinical 
phenotype cohort
Anthropometric data; blood pressure; 
HbA1c; chest Xray; sputum culture/Xpert; 
HIV viral load (if HIV positive)
All resident household members aged ≥15 years in the 
Population Intervention Platform (PIP) surveillance 
area (2018/2019)
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Pocket Profile – update of the Africa Centre Demographic Information System 
(ACDIS) cohort
Title:  Cohort Profile Update: Africa Centre Demographic Information System (ACDIS) 
and population-based HIV survey
Authors: Dickman Gareta1, Kathy Baisley1, Thobeka Mngomezulu1, Theresa Smit1, 
Thandeka Khoza1, Siyabonga Nxumalo1, Jaco Dreyer1, Sweetness Dube1, 
Nomathamsanqa Majozi1, Gregory Ording-Jesperson1 (The complete author list is 
available in the full version of the profile online).
Cite this as: The full version of this profile is available at IJE online and should be used 
when citing this profile.
Corresponding author: Dickman Gareta dickman.gareta@ahri.org
Keywords:  South Africa,  Cohort Profile, epidemiology, HIV, population cohort
The original cohort:  The Africa Centre Demographic Information System (ACDIS) 
cohort in rural KwaZulu Natal, South Africa, was established in 2000 to examine the 
impact of the HIV epidemic in rural South Africa. ACDIS covered 438 km2 and included 
approximately 85,000 individuals in 2006.   In 2017, the cohort was expanded to 
845 km2 to include communities of a recent cluster-randomised HIV ‘treatment as 
prevention’ trial, and renamed the Population Intervention Platform (PIP).
The new focus:  Public health priorities in South Africa have changed over the past 20 
years, with widespread ART availability and a growing burden of non-communicable 
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diseases (NCD).  The Africa Health Research Institute’s (AHRI; formerly the Africa 
Centre) research programme has shifted to address these new priorities, and to deliver 
and evaluate interventions.  The expanded surveillance area and new linkages to 
routine data sources provide a platform to measure population dynamics, disease 
burden, and health service usage, and to implement individual- and population-level 
interventions.  
Who is left?  In mid-2018, the PIP cohort had approximately 140,000 individuals 
(median age=23 years, IQR=11-36), of whom 66% were members of households in the 
original ACDIS area.
New measures:  AHRI continues to contact households up to three times annually to 
record household and individual measures.  New questions include additional 
household socioeconomic indicators, and diagnosis and treatment of HIV, TB and NCDs 
(Table 1).  Attendance at clinics in the PIP area is captured.  New linkages to routine 
data provide information on treatment, morbidity, health service usage, and a range of 
health outcomes.
Key new findings and/or unique features:  New findings have shown the tremendous 
benefit of antiretroviral therapy (ART) on adult life expectancy, and the impact of 
increased community- and household-level ART coverage, and scale-up of male 
circumcision, on the risk of HIV acquisition.  Recent studies have examined health 
service access, linkage to care and clinical outcomes.  One of PIP’s major strengths is its 
location and size: it is situated at the centre of dual HIV and TB epidemics and is one of 
the world’s largest population-based HIV surveillance studies, with wide-ranging 
longitudinal measures over 20 years.  The household survey has consistently high 
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response rates (>98%), providing nearly complete data on births, deaths and migration 
patterns.
Reasons to be cautious:  The individual component of the survey has a comparatively 
low response rate. However, a comprehensive sampling frame based on the household 
survey makes it possible to examine the extent to which representativeness is 
maintained and to quantify the effect of potential biases from non-participation. Other 
limitations are that most survey data are self-reported and linkage with routine data is 
imperfect, so some records may be incorrectly linked.
Collaboration and data access: Data can be accessed through the AHRI data repository 
(https://data.ahri.org/index.php/home), on completion of a data access request.  
Questionnaires and other documentation are also available on the repository.
Funding and competing interests: PIP is funded in part by the Wellcome Trust 
through core funding to AHRI, and by the South African Department of Science and 
Innovation through the South African Population Research Infrastructure Network 
(SAPRIN).  The authors declare no conflict of interest. 
Author affiliations:  1 Africa Health Research Institute, KwaZulu-Natal, South Africa
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Table 1. Additional data collected at household and individual surveys since the 
original cohort profile paper, and new linked data sources  
The measures described in the original cohort profile continue to be collected.  See full 
version of the profile update online for a complete description of information available.  
New information is highlighted below.








New questions added in 2006. 
Collected annually for 
households in surveillance area 




Receipt of government grants 
for old age, disability, child 
support, etc.
New questions added in 2006. 







When last tested 
negative/positive
Currently on antiretroviral 
therapy (ART)
New questions added in 2006, 
2010 and 2017.  Collected 
annually from all resident 
household members aged ≥15 
years
Sexual behaviour Contraceptive use (women)
Sexual activity 
Attitudes to condom use
New questions added in 2009, 
2010, 2011 and 2017.  Collected 
annually from all resident 
household members aged ≥15 
years




New questions added in 2009. 
Collected annually from all 
resident household members 
aged ≥15 years



































































Collected in 2010 from all 
resident household members 
aged ≥15 years 
Linked data sources
TIER.net Clinic visits for ART care; viral 
load; CD4 counts, ART regimen 
at initiation; changes in ART 
regimen
Electronic patient records for 
all individuals on ART in any of 
17 clinics in the Hlabisa health 





Admission date; discharge 
date; ward admitted to; ICD10 
diagnosis; discharge status
All admissions to Hlabisa 
hospital since 2010, except for 
routine deliveries
ClinicLink Date of visit; reason for visit All individuals attending one of 






pressure; HbA1c; chest Xray; 
sputum culture/Xpert; HIV 
viral load (if HIV positive)
All resident household 
members aged ≥15 years 































































Figure 1. Map of the expanded surveillance area. The Population Intervention Platform (PIP) includes the 
households of the original ACDIS surveillance area (southern PIP surveillancd area (SA)), and those of the 
recently completed Treatment as Prevention (TasP) trial (northern PIPSA) 































































Figure 2.  Age and sex profile of the surveillance population by residency status, 1 July 2018 (102,731 
residents; 39,348 non-residents) 
75x54mm (300 x 300 DPI) 































































Figure 3. Data gathered in PIP surveillance (green) and linked data sources, demonstrating the potential to 
address a range of health research questions across all the stages of the life course 
156x55mm (300 x 300 DPI) 































































Supplementary Figure S1. HIV prevalence by age and sex among residents participating in 2018 serosurvey 
75x54mm (300 x 300 DPI) 































































Supplementary Figure S2. Data gathered in Population Intervention Platform (PIP) demographic and HIV 
surveillance and linked data sources, with years of collection and total number of individuals in each 
database since inception, and the number who have been linked to household members in the PIP 
surveillance area. 
114x53mm (300 x 300 DPI) 
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